AHA Coding Clinic® for HCPCS - 2005 Issue 3; FOR your INFORMATION
New HCPCS codes for high osmolar contrast agents and Iloprost
New HCPCS drug codes were created for high osmolar contrast agents and for iloprost (inhalation solution), which became effective on July 1, 2005. The new codes are shown in Fig. 1. Fig. 1 New HCPCS codesShort descriptorLong descriptorQ4080 Iloprost inhalation solution Iloprost, inhalation solution, administered through DME, 20 mcg Q9958 HOCM <=149 mg="" ml="" iodine="" 1="" td=""> High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml Q9959 HOCM 150-199 mg/ml iodine, 1 ml High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml Q9960 HOCM 200-249 mg/ml iodine, 1 ml High osmolar contrast material, 200-249...
Subscribe or sign in to view the full article.
Article Overview
This premium article is about newly introduced HCPCS drug codes and the policy context surrounding them. It is useful for coders, billing staff, compliance teams, and other healthcare revenue cycle professionals who need to track coding updates, effective dates, and CMS-related guidance for drug reporting. The article presents the new code set additions, identifies the applicable service categories, and notes where to find further CMS information.
Why This Topic Matters
Updates like these affect how drug products are reported and how claims are processed under HCPCS. Knowing which new codes were added and when they became effective helps coding and billing teams stay aligned with current Medicare-related guidance.
Article Sections
-
New HCPCS drug codes
Introduces the newly created HCPCS drug codes and the effective date for their use. The section focuses on the overall scope of the update and the product categories involved.
-
Figure 1: New HCPCS codes
Presents the code listing included in the article for the relevant drug products. The section also reflects the source table format used to summarize the additions.
-
Payment context and CMS reference
Notes the payment-policy context discussed in the article and points readers to CMS transmittal information for additional details. This section frames the update within broader Medicare guidance.
What You Will Learn
- Which HCPCS drug code updates are discussed in the article
- What general product categories are covered by the new codes
- How the article frames the effective date and payment context
- Where the article directs readers for additional CMS information
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Compliance professionals
- Healthcare administrators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com